HIKMA FDA Approval ANDA 216206

ANDA 216206

HIKMA

FDA Drug Application

Application #216206

Application Sponsors

ANDA 216206HIKMA

Marketing Status

Prescription001

Application Products

001SOLUTION;INTRAVENOUS3MG/3ML (1MG/ML)0NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE

FDA Submissions

UNKNOWN; ORIG1AP2022-07-13STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216206
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEOSTIGMINE METHYLSULFATE","activeIngredients":"NEOSTIGMINE METHYLSULFATE","strength":"3MG\/3ML (1MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/13\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-07-13
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.